Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None AUD 0.00(0%)
Last update at 2025-09-26T06:45:05.439438Z
Market Cap
7.58M

Momentum Score

…

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.05
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
28.37M
Revenue Per Share
0.08
Gross Profit TTM
11.04M
Debt / Equity
0.64
ROE
-57.72%
Net Debt
18.76M
ROCE
-41.94%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -29.91M -21.75M -10.04M 17.25M 4.58M
Net income -39.91M -14.67M -6.99M 13.16M 6.00M
Selling general administrative 16.43M 16.00M 16.43M 14.98M 14.99M
Selling and marketing expenses 1.32M 2.26M 1.90M 2.87M 1.65M
Gross profit 17.28M 14.69M 17.62M 38.46M 25.77M
Reconciled depreciation 4.74M 5.07M 4.29M 2.05M 0.96M
Ebit -21.17M -20.37M -8.84M 17.39M 4.96M
Ebitda -16.43M -15.29M -4.55M 19.44M 5.92M
Depreciation and amortization 4.74M 5.07M 4.29M 2.05M 0.96M
Operating income -24.63M -22.51M -13.79M 10.91M 4.96M
Other operating expenses 13.58M 17.57M 13.54M 8.35M 32.51M
Interest expense 2.92M 1.38M 1.20M 0.14M 0.37M
Tax provision 10.01M -7.08M -3.06M 4.09M -1.42M
Interest income 2.92M 0.00M 1.20M 0.14M 0.37M
Net interest income -2.76M -1.38M -1.17M -0.14M -0.37M
Income tax expense 10.01M -7.08M -3.06M 4.09M -1.42M
Total revenue 32.51M 30.22M 28.79M 50.72M 35.60M
Total operating expenses 41.91M 37.21M 31.42M 27.55M 22.68M
Cost of revenue 15.23M 15.53M 11.17M 12.26M 9.83M
Total other income expense net -2.51M 2.14M 4.92M 6.22M -0.37M
Net income from continuing ops -39.91M -14.67M -6.99M 13.16M 6.00M
Net income applicable to common shares -39.91M -14.67M -6.99M 13.16M 6.00M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 71.25M 118.73M 149.55M 141.75M 84.30M
Intangible assets - 0.61M 4.28M 3.88M 0.66M
Other current assets 24.29M 1.31M 5.67M 6.34M 7.75M
Total liab 30.28M 44.09M 39.61M 29.95M 21.29M
Total stockholder equity 39.96M 74.63M 109.94M 111.80M 63.00M
Other current liab 0.03M 4.46M 5.92M 3.64M 9.67M
Common stock 120.81M 116.54M 115.35M 108.13M 62.38M
Capital stock - 116.54M 115.35M 108.13M 62.38M
Retained earnings -90.78M -65.92M -26.00M -11.33M -4.35M
Other liab - 11.93M 14.31M 13.69M -
Good will 25.27M 53.07M 51.09M 46.77M 46.77M
Other assets - 0.00M 9.67M 3.91M 2.49M
Cash 6.74M 7.29M 7.25M 8.62M 18.25M
Cash and equivalents - - 7.25M - -
Total current liabilities 20.78M 6.46M 8.07M 5.72M 10.70M
Current deferred revenue - -4.45M -5.88M -3.58M -8.84M
Net debt 18.76M 19.75M 12.46M 2.41M -7.17M
Short term debt 15.99M 1.33M 2.48M 0.49M 0.49M
Short long term debt - 1.00M 2.01M - -
Short long term debt total 25.49M 27.03M 19.71M 11.03M 11.08M
Other stockholder equity - -50.62M -89.34M -96.80M -58.03M
Property plant equipment - 43.43M 47.83M 47.99M 35.68M
Total current assets 37.37M 21.63M 36.69M 39.21M 45.46M
Net tangible assets - 20.95M 54.57M 61.16M 62.34M
Short term investments - 0.35M 0.20M 4.28M 14.13M
Net receivables 3.14M 2.88M 4.13M 4.48M 9.44M
Long term debt - 25.61M 16.77M 10.06M 10.00M
Inventory 3.21M 9.38M 15.70M 16.41M 10.01M
Accounts payable 4.75M 5.11M 5.56M 5.16M 9.38M
Accumulated other comprehensive income 9.93M 24.01M 20.60M 15.00M 4.97M
Common stock total equity - - - - 62.38M
Non currrent assets other - -97.11M -103.20M -98.63M -36.34M
Non current assets total 33.87M 97.11M 112.87M 102.54M 38.83M
Capital lease obligations - 0.43M 0.93M 0.96M 1.08M
Long term debt total - 25.70M 17.23M 10.54M 10.59M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -1.58M -3.00M -28.74M -22.53M -4.69M
Change to liabilities 9.61M -6.64M 0.91M -0.48M -1.31M
Total cashflows from investing activities -1.58M -3.00M -28.74M -22.53M -4.69M
Net borrowings 6.76M 8.18M -0.53M 9.40M -1.17M
Total cash from financing activities 7.64M 12.46M 28.57M 9.40M 25.11M
Change to operating activities -1.86M 1.84M 1.55M -1.92M -1.70M
Net income -39.91M -14.67M -6.99M 13.16M 6.00M
Change in cash 0.04M -1.37M -9.63M -7.49M 22.98M
Begin period cash flow 7.25M 8.62M 18.25M 25.74M 2.76M
End period cash flow 7.29M 7.25M 8.62M 18.25M 25.74M
Total cash from operating activities -6.91M -10.60M -8.36M 5.81M 2.44M
Issuance of capital stock 0.87M 4.28M 29.50M - 27.32M
Depreciation 4.55M 4.74M 4.11M 1.99M 0.96M
Other cashflows from investing activities 0.13M -0.01M 0.06M -0.13M 0.25M
Dividends paid - - - - 0.60M
Change to inventory 6.32M 0.71M -6.40M -3.44M -3.85M
Change to account receivables 4.16M 0.38M 5.17M -6.84M -1.86M
Sale purchase of stock 0.87M 4.28M 29.50M 0.00M -1.04M
Other cashflows from financing activities 8.77M 8.71M -0.39M 10.00M 0.60M
Change to netincome 6.16M -1.00M -2.77M 2.20M 3.79M
Capital expenditures 1.21M 2.67M 6.11M 22.61M 5.17M
Change in working capital 10.49M 1.09M -1.23M -10.28M 1.59M
Stock based compensation 0.68M 1.67M 1.77M 2.71M -
Other non cash items 28.46M -0.67M -5.48M -9.34M -6.96M
Free cash flow -8.12M -13.27M -14.46M -16.80M -2.74M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AFP
Aft Pharmaceuticals Ltd
-0.04
1.11%
3.55 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd
-0.06
2.22%
2.64 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd
-0.00
1.72%
0.06 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd
0.01
3.75%
0.41 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Ecofibre Ltd

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.

680 George Street, Sydney, NSW, Australia, 2000

61 7 3265 7630

Name Title Year Born
Mr. Eric Wang CEO, MD & Director NA
Mr. Jonathan Brown CFO & Joint Company Sec. NA
Dr. Alex Capano Chief Science Officer NA
Ms. Robin Sheldon Gen. Counsel & Joint Company Sec. NA
Mr. Kieren Brown Managing Director of Ananda Food NA
Mary Jakobi US Financial Controller NA
Kate Douglass Group Financial Controller NA
Mr. Jeff Bruner Pres of Hemp Black NA
Mr. Alex Nance Pres of Ananda Health NA
Ms. Vanessa Miscamble Wallace B.Comm (UNSW), MAICD, MBA Interim CEO, Interim MD & Chairman 1963

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…